Dr. Alexia R. Gospodinoff, MD

Dr. Gospodinoff practices at American Arthritis & Rheumatology Associates DC in Boca Raton, Florida.

Dr. Gospodinoff's NPI, 1578630869, was assigned on November 29, 2006. Dr. Gospodinoff holds Virginia license 0101055199.

Dr. Gospodinoff's primary practice is American Arthritis & Rheumatology Associates DC, at 2255 W Glades Rd, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (703) 689-2050.

Dr. Gospodinoff's primary practice is American Arthritis & Rheumatology Associates DC in Boca Raton, Florida. Dr. Gospodinoff is also affiliated with Inova Fair Oaks Hospital. The medical group on file is The American Arthritis and Rheumatology Associates (AARA). Dmand AI also links Dr. Gospodinoff to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gospodinoff practices, 8 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Gospodinoff's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Gospodinoff's licenses on file in 3 states: Virginia, District of Columbia and Maryland.

CMS data shows 123,652 Medicare services from Dr. Gospodinoff across 21 procedure codes in 2024, for 647 Medicare patients. Medicare paid $1,327,482 for them. Every service was in an office.

CMS counts 647 Medicare patients who saw Dr. Gospodinoff in 2024. The largest group is 65 to 74, with 314 patients. 75% of them have arthritis, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gospodinoff's median patient age at 65, with 76% women.

In 2024, Dr. Gospodinoff wrote 2,687 Medicare Part D claims for 372 patients. 84% of them were for generic drugs. CMS names the drug for 2,387 of them, across 40 drugs with 11 or more claims each, at $2,046,451 in total drug cost. In 2023, CMS named 2,041 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gospodinoff for performance year 2024, reported as part of a group. Dr. Gospodinoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gospodinoff as offering telehealth.

CMS Open Payments shows 1,895 general payments to Dr. Gospodinoff from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $4,871.